Focused on the intersection of tech and biotech, speed thrills Foresite Capital’s new $969M fund

The founder and CEO of the venture capital firm, which has backed fast-moving companies at the intersection of tech and biotech, talks about its fifth fund, SPACs and the wealth of cycle-experienced entrepreneurs. Source: https://www.bizjournals.com/sanfrancisco/news/2021/02/26/foresite-capital-spac-fifth-fund-txg-lyell-nirx.html?ana=brss_2152